<DOC>
	<DOCNO>NCT00369044</DOCNO>
	<brief_summary>We design , randomize , double-blind , placebo-controlled trial determine clinical efficacy chronic administration prednisone renal function clinical status add standard care .</brief_summary>
	<brief_title>Prednisone Decompensated Congestive Heart Failure</brief_title>
	<detailed_description>Studies show glucocorticoid could specifically dilate renal vessel , increase GFR , regulate synthesis release atrial natriuretic peptide ( ANP ) , upregulate ANP receptor vascular endothelial cell , lead significant diuresis natriuresis . Adding glucocorticoids standard care may potentiate diuretic natriuretic effect diuretic improve renal function , thus improve clinical outcome .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Hospitalized primary diagnosis CHF Patients normal cortical function LVEF &lt; 40 % Significant fluid overload , define ≥ 2 follow Enlarged liver ascites Peripheral sacral edema ( ≥ 2+ ) Jugular venous distention ≥ 10 cm Pulmonary rale , pleural effusion chest xray orthopnea Severe stenotic valvular disease Serum creatinine &gt; 4 mg/dl Patient refusal Any sign infection condition would contraindicate glucocorticoid use Poor control hypertension Poor control diabetes mellitus Active myocarditis Malignancy terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>decompensated heart failure</keyword>
	<keyword>prednisone</keyword>
	<keyword>diuretic</keyword>
	<keyword>diuresis</keyword>
</DOC>